January 2025

Celltrion and Amgen Reach Settlement in Prolia® / Xgeva® Biosimilar Litigation | Venable LLP

On January 24, 2025, Amgen announced it had reached a settlement with Celltrion in Case No. 1:24-cv-06497 (D.N.J.) related to Celltrion’s proposed biosimilar of Prolia® / Xgeva® (denosumab), CT-P41.  The lawsuit involved allegations of infringement of 29 of Amgen’s patents (previously reported Amgen Files BPCIA Lawsuit Against Celltrion’s Proposed Prolia® / Xgeva® (Denosumab) Biosimilar CT-P41).  […]

Celltrion and Amgen Reach Settlement in Prolia® / Xgeva® Biosimilar Litigation | Venable LLP Read More »

Last week’s conferences in Asia

Last week I gave two presentations in Asia.  On Monday, I presented The Law and Economics of Wrongful Patent Assertion at IEEM (Instituto de Estudos Europeus de Macau)’s 20th Intellectual Property Seminar, “Proportionality in Intellectual Property Law,” in Macau, S.A.R.  The presentation summarized some of my current book project, Wrongful Patent Assertion:  A Comparative Law

Last week’s conferences in Asia Read More »

When Is a Published Patent Application Prior Art? | Dorsey & Whitney LLP

In a precedential opinion entered on January 14, 2025, the United States Court of Appeals for the Federal Circuit affirmed a decision of the Patent Trial and Appeal Board (“PTAB”) invalidating claims of a patent on obviousness grounds under 35 U.S.C. § 103. A key issue in the case was the date upon which a

When Is a Published Patent Application Prior Art? | Dorsey & Whitney LLP Read More »

Last week’s conferences in Asia

Last week I gave two presentations in Asia.  On Monday, I presented The Law and Economics of Wrongful Patent Assertion at IEEM (Instituto de Estudos Europeus de Macau)’s 20th Intellectual Property Seminar, “Proportionality in Intellectual Property Law,” in Macau, S.A.R.  The presentation summarized some of my current book project, Wrongful Patent Assertion:  A Comparative Law

Last week’s conferences in Asia Read More »

Teva Branded Pharm. Products R&D, Inc. v. Amneal Pharms. of NY, LLC | Robins Kaplan LLP

ProAir® HFA (albuterol sulfate) Case Name: Teva Branded Pharm. Products R&D, Inc. v. Amneal Pharms. of NY, LLC, No. 2024-1936, 2024 WL 5176737 (Fed. Cir. Dec. 20, 2024) (Circuit Judges Prost, Taranto, and Hughes presiding; Opinion by Prost, J.) (Appeal from D.N.J., Chesler, J.)  Drug Product and Patent(s)-in-Suit: ProAir® HFA (albuterol sulfate); U.S. Patents Nos. 8,132,712

Teva Branded Pharm. Products R&D, Inc. v. Amneal Pharms. of NY, LLC | Robins Kaplan LLP Read More »

Last week’s conferences in Asia

Last week I gave two presentations in Asia.  On Monday, I presented The Law and Economics of Wrongful Patent Assertion at IEEM (Instituto de Estudos Europeus de Macau)’s 20th Intellectual Property Seminar, “Proportionality in Intellectual Property Law,” in Macau, S.A.R.  The presentation summarized some of my current book project, Wrongful Patent Assertion:  A Comparative Law

Last week’s conferences in Asia Read More »

Last week’s conferences in Asia

Last week I gave two presentations in Asia.  On Monday, I presented The Law and Economics of Wrongful Patent Assertion at IEEM (Instituto de Estudos Europeus de Macau)’s 20th Intellectual Property Seminar, “Proportionality in Intellectual Property Law,” in Macau, S.A.R.  The presentation summarized some of my current book project, Wrongful Patent Assertion:  A Comparative Law

Last week’s conferences in Asia Read More »

Unpacking Defamation and Free Speech in Play Games 24×7 v. Skoch Group – The IP Press

In a digital era where rankings and reviews significantly influence consumer choices, what happens when these rankings are alleged to be biased, defamatory, and self-serving? This question takes center stage in the recent case of Play Games 24×7 Private Limited v. Skoch Group & Ors.[1], heard by the Delhi High Court. The dispute brings to

Unpacking Defamation and Free Speech in Play Games 24×7 v. Skoch Group – The IP Press Read More »

Last week’s conferences in Asia

Last week I gave two presentations in Asia.  On Monday, I presented The Law and Economics of Wrongful Patent Assertion at IEEM (Instituto de Estudos Europeus de Macau)’s 20th Intellectual Property Seminar, “Proportionality in Intellectual Property Law,” in Macau, S.A.R.  The presentation summarized some of my current book project, Wrongful Patent Assertion:  A Comparative Law

Last week’s conferences in Asia Read More »

NIL News: End of Year Roundup — Highway to NIL Podcast | Troutman Pepper Locke

The Highway to NIL Podcast analyzes the legal landscape concerning college athletics and the regulation of name, image, and likeness (NIL) rights of student athletes. The podcast provides key insights into the current state of affairs, focusing on the NIL guidance and policies coming directly from the NCAA; the various passed and amended state NIL

NIL News: End of Year Roundup — Highway to NIL Podcast | Troutman Pepper Locke Read More »